For example, in gastric cancer, ATXN2L expression is upregulated by EGF, which activates the PI3K/AKT signaling pathway, promoting epithelial-mesenchymal transition (EMT), migration, and invasion, all associated with a poor prognosis in gastric cancer. This evidence concerns the gene EGF and gastric cancer.